Literature DB >> 23832319

Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?

S Sassen1, M de Booij, M Sosef, R Berendsen, G Lammering, R Clarijs, M Bakker, R Beets-Tan, F Warmerdam, R Vliegen.   

Abstract

OBJECTIVES: To determine retrospectively the additional value of DWI-MRI toT2-MRI for predicting complete response (ypT0N0 = CR) after chemoradiation-therapy (CRT) in locally advanced rectal cancer.
METHODS: Seventy locally advanced rectal cancer patients underwent CRT followed by restaging MRI and resection. Two readers with different experience levels independently scored T2 images for CR and, in a second reading, combined T2 and DWI. A 5-point confidence-level score was used to generate ROC curves. Areas under the ROC curves (AUC) and interobserver agreement were compared for both readings. Histology served as reference standard.
RESULTS: The interobserver agreement increased after addition of DWI from 0.35 to 0.58 but the AUC improved only for the experienced reader (0.77 to 0.89, p = 0.005 vs. 0.74 to 0.70, p > 0.05). Sensitivity and NPV improved from 20-30 % to 40-70 %, respectively 88 % to 91-95 %. Specificity and PPV improved only for the experienced reader (87 to 93 % respectively 27 to 63 %).
CONCLUSION: Adding DWI to T2-MRI improves consistency between readers and has potential to improve readers' accuracy dependent on his/her experience. DWI could be of additional value, particularly in ruling out CR (high NPV), but considering the sub-optimal PPV one should be cautious about relying solely on MRI for the clinical decision to offer a wait-and-see strategy.

Entities:  

Mesh:

Year:  2013        PMID: 23832319     DOI: 10.1007/s00330-013-2956-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Fábio G Campos; Wladimir Nadalin; Desiderio Kiss; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

2.  Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.

Authors:  I Song; S H Kim; S J Lee; J Y Choi; M J Kim; H Rhim
Journal:  Br J Radiol       Date:  2011-02-22       Impact factor: 3.039

3.  Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?

Authors:  R Hughes; R Glynne-Jones; J Grainger; P Richman; A Makris; M Harrison; R Ashford; R A Harrison; J I Livingstone; P J McDonald; J Meyrick Thomas; I C Mitchell; J M A Northover; R Phillips; M Wallace; A Windsor; J R Novell
Journal:  Int J Colorectal Dis       Date:  2005-04-30       Impact factor: 2.571

4.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

5.  Patterns of response after preoperative intensity-modulated radiation therapy and capecitabine/oxaliplatin in rectal cancer: is there still a place for ecoendoscopic ultrasound?

Authors:  Leire Arbea; Juan A Díaz-González; Jose Carlos Subtil; Josu Sola; Jose Luis Hernandez-Lizoain; Rafael Martínez-Monge; Marta Moreno; Javier Aristu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-26       Impact factor: 7.038

6.  Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thin-section T2-weighted magnetic resonance imaging.

Authors:  Dow-Mu Koh; Ian Chau; Diana Tait; Andrew Wotherspoon; David Cunningham; Gina Brown
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

7.  Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Authors:  Seung Ho Kim; Jeong Min Lee; Hee Sun Park; Hyo Won Eun; Joon Koo Han; Byung Ihn Choi
Journal:  J Magn Reson Imaging       Date:  2009-05       Impact factor: 4.813

8.  Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?

Authors:  Max J Lahaye; Geerard L Beets; Sanne M E Engelen; Alfons G H Kessels; Adriaan P de Bruïne; Herry W S Kwee; Jos M A van Engelshoven; Cornelis J H van de Velde; Regina G H Beets-Tan
Journal:  Radiology       Date:  2009-04-29       Impact factor: 11.105

9.  The role of local excision in rectal cancer after complete response to neoadjuvant treatment.

Authors:  C Coco; A Manno; C Mattana; A Verbo; G Rizzo; V Valentini; M A Gambacorta; F M Vecchio; D D'Ugo
Journal:  Surg Oncol       Date:  2007-11-26       Impact factor: 3.279

10.  Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction.

Authors:  Roy F A Vliegen; Geerard L Beets; Guido Lammering; Raphaëla C Dresen; Harm J Rutten; Alfons G Kessels; Toen-Khiam Oei; Adriaan P de Bruïne; Jos M A van Engelshoven; Regina G H Beets-Tan
Journal:  Radiology       Date:  2008-02       Impact factor: 11.105

View more
  29 in total

Review 1.  Recent developments in colorectal imaging.

Authors:  Perry J Pickhardt
Journal:  Curr Opin Gastroenterol       Date:  2015-01       Impact factor: 3.287

Review 2.  Multimodal imaging evaluation in staging of rectal cancer.

Authors:  Suk Hee Heo; Jin Woong Kim; Sang Soo Shin; Yong Yeon Jeong; Heoung-Keun Kang
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

3.  Diffusion-weighted MRI to assess response to chemoradiotherapy in rectal cancer: main interpretation pitfalls and their use for teaching.

Authors:  Doenja M J Lambregts; Miriam M van Heeswijk; Andrea Delli Pizzi; Saskia G C van Elderen; Luisa Andrade; Nicky H G M Peters; Peter A M Kint; Margreet Osinga-de Jong; Shandra Bipat; Rik Ooms; Max J Lahaye; Monique Maas; Geerard L Beets; Frans C H Bakers; Regina G H Beets-Tan
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

Review 4.  Diffusion-weighted imaging in rectal cancer: current applications and future perspectives.

Authors:  Niels W Schurink; Doenja M J Lambregts; Regina G H Beets-Tan
Journal:  Br J Radiol       Date:  2019-03-05       Impact factor: 3.039

5.  The split scar sign as an indicator of sustained complete response after neoadjuvant therapy in rectal cancer.

Authors:  Inês Santiago; Maria Barata; Nuno Figueiredo; Oriol Parés; Vanessa Henriques; António Galzerano; Carlos Carvalho; Celso Matos; Richard J Heald
Journal:  Eur Radiol       Date:  2019-07-26       Impact factor: 5.315

Review 6.  Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer.

Authors:  Trang T Pham; Gary P Liney; Karen Wong; Michael B Barton
Journal:  Br J Radiol       Date:  2017-03-07       Impact factor: 3.039

7.  Pelvic MRI after induction chemotherapy and before long-course chemoradiation therapy for rectal cancer: What are the imaging findings?

Authors:  Marc J Gollub; Ivana Blazic; David D B Bates; Naomi Campbell; Andrea Knezevic; Mithat Gonen; Patricio Lynn; Martin R Weiser; Julio Garcia-Aguilar; Andreas M Hötker; Andrea Cercek; Leonard Saltz
Journal:  Eur Radiol       Date:  2018-10-02       Impact factor: 5.315

Review 8.  Gastrointestinal imaging-practical magnetic resonance imaging approach.

Authors:  Baodong Liu; Miguel Ramalho; Mamdoh AlObaidy; Kiran K Busireddy; Ersan Altun; Janaka Kalubowila; Richard C Semelka
Journal:  World J Radiol       Date:  2014-08-28

9.  MRI for evaluation of treatment response in rectal cancer.

Authors:  Ivana M Blazic; Naomi M Campbell; Marc J Gollub
Journal:  Br J Radiol       Date:  2016-06-22       Impact factor: 3.039

Review 10.  Endoscopic and MRI response evaluation following neoadjuvant treatment for rectal cancer: a pictorial review with matched MRI, endoscopic, and pathologic examples.

Authors:  Seth I Felder; Sebastian Feuerlein; Arthur Parsee; Iman Imanirad; Julian Sanchez; Sophie Dessureault; Richard Kim; Sarah Hoffe; Jessica Frakes; James Costello
Journal:  Abdom Radiol (NY)       Date:  2020-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.